Sartorius · 13 hours ago
Research Intern - LNP Formulation - Onsite - Marlborough, MA
Sartorius is a growing global life science company focused on translating scientific discoveries into real-world medicine. In this Research Intern role, you will contribute to the development and integration of emerging technologies for formulation and characterization of Lipid Nanoparticles, collaborating closely with engineers and scientists in a multidisciplinary environment.
BiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Establish, execute, and maintain protocols for the preparation and
Design and conduct DOE-driven formulation and process optimization
Perform in vitro assays to assess transfection efficiency and delivery of
Support process development activities for LNP screening, scale-up, and
Assist in programming, operating, and optimizing automated liquid handling
Collect, analyze, and interpret experimental data; prepare technical
Qualification
Required
PhD graduate or student in Bioengineering, or closely related discipline with formal education and experience with lipid Nanoparticles
Hands-on experience with LNP formulation characterization techniques and biological assays used to evaluate key LNP properties
Experience with mammalian cell culture and maintenance
Experience with DOE and basic statistical analysis tools for experimental design and data interpretation
Identification with our core values: Sustainability, Openness, Enjoyment
Company
Sartorius
Sartorius helps its customers to develop and manufacture biotech medicines reliably, quickly, and economically. It is a sub-organization of Sartorius.
H1B Sponsorship
Sartorius has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (16)
2024 (27)
2023 (14)
2022 (21)
2021 (24)
2020 (7)
Funding
Current Stage
Public CompanyTotal Funding
$3.21B2023-09-07Post Ipo Debt· $3.21B
1990-07-10IPO
Leadership Team
Recent News
2026-01-16
Company data provided by crunchbase